Status:
COMPLETED
Medication Exposure in Older Patients With Constitutional Hemorrhagic Disease
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
Hemophilia
Eligibility:
All Genders
Up to 65 years
Brief Summary
The improvements observed in the care of patients with hemophilia or Willebrand disease have led to an increase in their life expectancy, which today approaches that of the general population. This in...
Eligibility Criteria
Inclusion
- Community-dwelling patients over 65 years with hemophilia (A or B)
- Community-dwelling patients over 65 years with Willebrand disease (Type1, 2 and 3, rate \<30%)
Exclusion
- Patients without phone number
- Non French speaking patients
Key Trial Info
Start Date :
July 22 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 29 2021
Estimated Enrollment :
142 Patients enrolled
Trial Details
Trial ID
NCT04282486
Start Date
July 22 2020
End Date
January 29 2021
Last Update
July 13 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital des Charpennes, Institut du Vieillissement
Villeurbanne, France, 69100